![Michael Narachi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 1 M $ in data 30/06/2026
Michael A. Narachi is an Independent Director at Ultragenyx Pharmaceutical, Inc. since 2015.
Formerly, Mr. Narachi was President, Chief Executive Officer & Director at CODA Biotherapeutics, Inc. from 2018 to 2022; President, Chief Executive Officer & Director at Orexigen Therapeutics, Inc. from 2016 to 2018; Chairman, President & Chief Executive Officer at Ren Pharmaceuticals, Inc. from 2006 to 2009; Chairman at Celladon Corp.
from 2013 to 2016; Executive Chairman at Naryx Pharma, Inc. from 2002 to 2008; Director at Pharmaceutical Research & Manufacturers of America from 2013 to 2017; Director at AMAG Pharmaceuticals, Inc. in 2014; Vice President at Amgen, Inc. from 1984 to 2003; and held director and vice president roles at Thousand Oaks Corp., Biotechnology Innovation Organization, and Amgen KK.
Education includes undergraduate and graduate degrees from the University of California, Davis, and an MBA from UCLA Anderson School of Management.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 14/05/2026 | 40.441 ( 0,04% ) | 1 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Direttore/Membro del Consiglio | 20/02/2015 |
| Società | Posizione | Fine |
|---|---|---|
CODA Biotherapeutics, Inc.
 CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology Develops chemo genetic neuromodulation platform for the treatment of severe neurological disorders | Amministratore Delegato | 01/10/2022 |
| OREXIGEN THERAPEUTICS, INC. | Amministratore Delegato | 01/08/2018 |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Direttore/Membro del Consiglio | 01/04/2017 |
Celladon Corp.
 Celladon Corp. BiotechnologyHealth Technology Develops molecular therapies for cardiovascular diseases | Presidente | 01/03/2016 |
| AMAG PHARMACEUTICALS, INC. | Presidente | 15/04/2014 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 14 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Celladon Corp.
Celladon Corp. BiotechnologyHealth Technology Develops molecular therapies for cardiovascular diseases | Health Technology |
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on the treatment of obesity | Health Technology |
Naryx Pharma, Inc.
 Naryx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops products for the treatment of chronic sinusitis | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Ren Pharmaceuticals, Inc.
 Ren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceuticals products | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Amgen KK
 Amgen KK Pharmaceuticals: MajorHealth Technology Engages in developing pharmaceuticals | Health Technology |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thousand Oaks Corp.
 Thousand Oaks Corp. Wholesale DistributorsDistribution Services Wholesales sporting goods | Distribution Services |
CODA Biotherapeutics, Inc.
CODA Biotherapeutics, Inc. Medical SpecialtiesHealth Technology Develops chemo genetic neuromodulation platform for the treatment of severe neurological disorders | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
